The gadopiclenol extension for use in infants and neonates offers high-quality MRI contrast enhancement at half the standard gadolinium dose. The FDA has approved an extension of intravenous ...

National survey data show a 35% increase in child mental health conditions since 2016, with one-quarter of households reporting unmet treatment needs.

Nontargeted testing identified 42 PFAS in cord blood, far exceeding the 8 compounds measured by traditional targeted methods, suggesting broader prenatal exposure. Cumulative exposure estimates ...

Phase 2 data suggest FcRn blockade may reduce maternal IgG and placental antibody transfer in HDFN without excess infant infections. Hemolytic disease of the fetus and newborn (HDFN) remains a serious ...

Wondering how to counsel parents on keeping their child’s immune system healthy through nutrition? Check out these clinical pearls from Colleen Sloan, PPA-C, RDN.

Sophie Driker, MPH, and Anne CC Lee, MD, MPH, discuss the effectiveness of WHO IMCI clinical signs for detecting sepsis and mortality risk in infants younger than 60 days.

In the phase 3 KALOS and LOGOS trials, single-inhaler fixed-dose triple therapy Breztri Aerosphere significantly improved lung function and reduced severe exacerbation rates vs dual-combination ...

Experts discuss whole-foods emphasis, microbiome insights, and consumer-focused changes in the 2025–2030 US Dietary Guidelines for clinicians. In a Special Report, presented by Contemporary Pediatrics ...

CRL focused on usability, not efficacy or manufacturing: The FDA’s Complete Response Letter for Anaphylm cited deficiencies limited to human factors, labeling, and a single supportive PK study; no CMC ...

Roflumilast cream 0.05% was well tolerated in infants aged 3 months to <24 months, with no serious adverse events and only one treatment discontinuation in the Phase 2 INTEGUMENT-INFANT study.

AbbVie submitted FDA and EMA applications seeking approval of upadacitinib (RINVOQ) 15 mg once daily for adults and adolescents aged 12 years and older with non-segmental vitiligo. Phase 3 Viti-Up ...